These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38227942)

  • 21. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
    von Stockum S; Becker K; Bauerfeind A; Franke C; Fruzzetti F; Calaf J; Keck C; Heinemann K
    Gynecol Endocrinol; 2023 Dec; 39(1):2166032. PubMed ID: 36690019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
    J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studies.
    Barnett C; Bauerfeind A; Von Stockum S; Heinemann K
    AJOG Glob Rep; 2022 Feb; 2(1):100041. PubMed ID: 36274960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quadriphasic versus monophasic oral contraceptives for contraception.
    Van Vliet HA; Raps M; Lopez LM; Helmerhorst FM
    Cochrane Database Syst Rev; 2011 Nov; (11):CD009038. PubMed ID: 22071862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethinyl estradiol vs estradiol valerate in combined oral contraceptives - Effect on glucose tolerance: A randomized, controlled clinical trial.
    Haverinen A; Kangasniemi M; Luiro K; Piltonen T; Heikinheimo O; Tapanainen JS
    Contraception; 2021 Jan; 103(1):53-59. PubMed ID: 33098852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
    Haverinen AH; Luiro KM; Szanto T; Kangasniemi MH; Hiltunen L; Sainio S; Piltonen TT; Lassila R; Tapanainen JS; Heikinheimo O
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1102-1111. PubMed ID: 35909329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Kangasniemi MH; Arffman RK; Haverinen A; Luiro K; Hustad S; Heikinheimo O; Tapanainen JS; Piltonen TT
    Contraception; 2022 Dec; 116():59-65. PubMed ID: 36084710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous estradiol metabolism during treatment with oral contraceptives.
    Mueck AO; Seeger H; Wallwiener D
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):160-4. PubMed ID: 15049436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic impact of combined hormonal contraceptives containing estradiol.
    Grandi G; Napolitano A; Cagnacci A
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):779-87. PubMed ID: 27187588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest.
    Fruzzetti F; Trémollieres F; Bitzer J
    Gynecol Endocrinol; 2012 May; 28(5):400-8. PubMed ID: 22468839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
    Larivée N; Suissa S; Eberg M; Joseph L; Eisenberg MJ; Abenhaim HA; Filion KB
    BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice?
    Piacenti I; Viscardi MF; Masciullo L; Sangiuliano C; Scaramuzzino S; Piccioni MG; Muzii L; Benedetti Panici P; Porpora MG
    Gynecol Endocrinol; 2021 May; 37(5):471-475. PubMed ID: 33650928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.
    Jick SS; Hagberg KW; Hernandez RK; Kaye JA
    Contraception; 2010 Jan; 81(1):16-21. PubMed ID: 20004268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives.
    Hoffmann H; Moore C; Zimmermann H; Elger W; Schwarz S; Gräser T; Oettel M
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):458-64. PubMed ID: 9784023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol.
    Grandi G; Xholli A; Napolitano A; Piacenti I; Bellafronte M; Cagnacci A
    Contraception; 2014 Nov; 90(5):529-34. PubMed ID: 24962542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
    J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.